title: Reduction in PCSK9 levels induced by anacetrapib: an off-target effect?
authors.affiliation: School of Medical Sciences, University of New South Wales Australia, Sydney, Australia p.barter@unsw.edu.au.
authors.forename: Philip J
authors.initials: PJ
authors.lastname: Barter
authors.affiliation: School of Medical Sciences, University of New South Wales Australia, Sydney, Australia.
authors.forename: Fatiha
authors.initials: F
authors.lastname: Tabet
authors.affiliation: School of Medical Sciences, University of New South Wales Australia, Sydney, Australia.
authors.forename: Kerry-Anne
authors.initials: KA
authors.lastname: Rye
mesh_terms: D053480:Cholesterol Ester Transfer Proteins; D006801:Humans; D043484:Proprotein Convertases / Q000378:metabolism; D012697:Serine Endopeptidases / Q000378:metabolism*
chemical_list: D053480:Cholesterol Ester Transfer Proteins; D043484:Proprotein Convertases; D012697:Serine Endopeptidases